| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Molecular and Cellular Physiology, Louisiana State University Medical Center, School of Medicine in Shreveport, Shreveport, Louisiana 71130; and Department of Anatomy and Physiology, Kansas State University, College of Veterinary Medicine, Manhattan, Kansas 66506
We and others have previously demonstrated that intestinal ischemia-reperfusion (I/R) is associated with a large increase in oxidant production that contributes to microvascular barrier disruption in the small bowel. It has been suggested that the bulk of tissue damage during reperfusion can be attributed to adherent, activated neutrophils. From these observations, we hypothesized that pretreatment with PR-39, an endogenous neutrophil antibacterial peptide that is also a potent inhibitor of the neutrophil NADPH oxidase, would prevent postischemic oxidant production and the development of oxidant-dependent sequelae to I/R such as increased venular protein leakage. To test this postulate, oxidant production, venular protein leakage, leukocyte adhesion, and leukocyte emigration were monitored during reperfusion in control (no ischemia) rat mesenteric venules and in mesenteric venules subjected to I/R alone or PR-39 + I/R. Treatment with a single intravenous bolus injection of PR-39 (administered at a dose to achieve an initial blood concentration of 5 µM) abolished I/R-induced leukocyte adhesion and emigration in vivo. In vitro studies indicated that PR-39 prevents platelet-activating factor-induced neutrophil chemotaxis as well as phorbol myristate acetate (PMA)-stimulated intercellular adhesion molecule-1 expression by cultured endothelial cells. PR-39 pretreatment of rat neutrophils also blocked PMA-stimulated neutrophil adhesion to activated endothelial monolayers. In vivo, I/R was associated with a marked and progressive increase in oxidant production and venular protein leakage during reperfusion, effects that were abolished by PR-39 treatment. The results of this study indicate that PR-39 completely abolishes postischemic leukocyte adhesion and emigration. The time course for inhibition of oxidant production by PR-39 suggests that its antiadhesive properties account for this effect of the peptide. PR-39 may thus be therapeutically useful for prevention of neutrophil adhesion and activation during the postischemic inflammatory response.
leukocyte adhesion; leukocyte emigration; venular protein leakage; oxidant production; intravital microscopy; intercellular adhesion molecule-1
This article has been cited by other articles:
|
|
 |
|
  D. Wang, W. Ma, R. She, Qu. Sun, Y. Liu, Y. Hu, L. Liu, Y. Yang, and K. Peng Effects of swine gut antimicrobial peptides on the intestinal mucosal immunity in specific-pathogen-free chickens Poult. Sci., May 1, 2009; 88(5): 967 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yusof, K. Kamada, F. Spencer Gaskin, and R. J. Korthuis Angiotensin II mediates postischemic leukocyte-endothelial interactions: role of calcitonin gene-related peptide Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3032 - H3037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Powell The ubiquitin-proteasome system in cardiac physiology and pathology Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H1 - H19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Petnehazy, D. Cooper, K. Y. Stokes, J. Russell, K. C. Wood, and D. N. Granger Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1203 - G1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shigematsu, S. Ishida, D. C. Gute, and R. J. Korthuis Bradykinin-induced proinflammatory signaling mechanisms Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2676 - H2686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bao, K. Sato, M. Li, Y. Gao, R. Abid, W. Aird, M. Simons, and M. J. Post PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated Ikappa Balpha degradation Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2612 - H2618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Hoffmeyer, R. Scalia, C. R. Ross, S. P. Jones, and D. J. Lefer PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2824 - H2828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Hoffmeyer, S. P. Jones, C. R. Ross, B. Sharp, M. B. Grisham, F. S. Laroux, T. J. Stalker, R. Scalia, and D. J. Lefer Myocardial Ischemia/Reperfusion Injury in NADPH Oxidase-Deficient Mice Circ. Res., October 27, 2000; 87(9): 812 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Akgur, M. F. Brown, G. B. Zibari, J. C. McDonald, C. J. Epstein, C. R. Ross, and D. N. Granger Role of superoxide in hemorrhagic shock-induced P-selectin expression Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H791 - H797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Rey, M. E. Cifuentes, A. Kiarash, M. T. Quinn, and P. J. Pagano Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2- and Systolic Blood Pressure in Mice Circ. Res., August 31, 2001; 89(5): 408 - 414. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
